Intragastric Balloons Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Intragastric Balloons Market From 2025 To 2034?

The market for intragastric balloons has experienced an accelerated expansion lately; projections indicate a rise from a valuation of $19.89 billion in 2024 to $22.05 billion in 2025, reflecting a ten-point-nine percent compound annual growth rate over that span. This upward trajectory in the past duration is assignable to several interconnected factors, including escalating obesity prevalence, increased spending on healthcare services, the accrual of supporting clinical data alongside the attainment of FDA authorizations, proactive public awareness initiatives, enhancements in balloon engineering, and burgeoning medical tourism activities.

Anticipating substantial expansion, the market for intragastric balloons is projected to reach a valuation of $33.15 billion by the year 2029, exhibiting a consistent compound annual growth rate of 10.7% throughout the coming years; this upward trajectory is propelled by factors such as endorsements from public figures, the rising prevalence of health concerns linked to weight, market penetration in developing economies, a greater frequency of endoscopic interventions, demographic shifts toward an older populace, and the adoption of customized treatment modalities, while key developments shaping this period involve advancements in technology, greater visibility fostered by social media engagement, the interconnectivity with digital healthcare systems, the incorporation of artificial intelligence, remote consultation opportunities, and more comprehensive patient educational initiatives.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

What Are The Top Growth Drivers Impacting The Intragastric Balloons Market Outlook?

Elevated occurrences of obesity are anticipated to stimulate the expansion of the intragastric balloon sector in the foreseeable future.Obesity prevalence signifies the proportion or count within a populace classified as obese, typically determined by a Body Mass Index (BMI) reaching 30 or exceeding that value.Factors contributing to the rise in obesity encompass shifts in eating patterns, limited physical activity, financial considerations, promotional activities, inherent genetic makeup and biological processes, emotional and mental states, alongside the effects of city development and existing structures.Individuals struggling with obesity frequently opt for intragastric balloons as a surgical alternative for weight management, achieved by the device physically filling stomach volume, thus fostering satiety and subsequently limiting the amount of food consumed.To illustrate this impact, data from the World Obesity Federation, a charitable entity based in the UK, presented in the World Obesity Atlas 2022 in March 2023, forecasts that the worldwide financial burden linked to being overweight and obese could escalate to an annual figure of $4.32 trillion by 2035 absent any modifications to current treatment and prevention strategies.Furthermore, projections indicate that by that same year, upwards of half the global inhabitants—specifically 51%, translating to over four billion persons—may be impacted by being overweight or obese, with approximately two billion people, equating to one in every four individuals, projected to meet the criteria for obesity should present trajectories persist.Consequently, the escalating rates of obesity serve as a key catalyst pushing the growth trajectory of the intragastric balloon market.

What Are The Major Segment Categories Driving The Intragastric Balloons Market Growth?

The intragastric balloonsmarket covered in this report is segmented –

1) By Type: Single, Dual, Triple Intragastric Balloons

2) By Filling Material: Saline Filled, Gas Filled

3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies

4) By Application Areas: Obesity, Diabetes, Diet Control, Weight-loss, Pre-operative Weight Reduction, Other Applications

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon

2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon

3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon

What Trends Are Expected To Drive The Intragastric Balloons Market?

Leading firms within the intragastric balloon sector are currently concentrating efforts on innovating next-generation medical treatments for obesity, specifically the ingestible gastric balloon, aiming to substantially improve patient convenience, operational simplicity, and market availability. These orally administered gastric balloons represent non-invasive tools designed to assist in shedding weight by physically taking up volume within the stomach lining, thereby fostering satiety and consequently decreasing the quantity of food consumed. As an illustration, during September of 2022, the American medical technology firm Allurion Technologies Inc. introduced its swallowable gastric balloon capsule into the Indian market, marking the debut of the planet’s initial non-surgical, ingestible gastric balloon system that foregoes the necessity for endoscopic procedures or sedation during either implantation or explantation. The specialized gastric balloon offered by Allurion provides a secure, incisionless, and efficacious method for weight management, enabling people to attain meaningful reductions in body weight and cultivate sustainable healthy routines crucial for lasting positive outcomes.

Which Industry Leaders Are Driving Innovation Across The Intragastric Balloons Market?

Major companies operating in the intragastric balloons market are Medtronic plc, Mayo Clinic, Boston Scientific Corporation, Cleveland Clinic, Mediclinic Group, Spire Healthcare Group plc, Micro-Tech (Nanjing) Co., Ltd., American Hospital Dubai LLC, Silimed GmbH, Apollo Endosurgery Inc., Allurion Technologies Inc., MedicalExpo, ReShape Lifesciences Inc., Districlass Medical SA, Healthware Private Limited, Spatz Medical, Helioscopie SA, Bariatric Solutions International GmbH, HexaHealth Care Pvt. Ltd., USGI Medical Inc., Inamed Health, Medsil, Obalon Therapeutics Inc., Endalis, Lexel SRL

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Intragastric Balloons Market?

North America was the largest region in the intragastric balloons market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Intragastric Balloons Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15835&type=smp

Browse Through More Reports Similar to the Global Intragastric Balloons Market 2025, By The Business Research Company

Gastric Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Cancer Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market

Gastric Volvulus Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795